XENOGENEIC EXTRACELLULAR MATRIX GRAFTS ELICIT A TH2-RESTRICTED IMMUNE RESPONSE1
Abstract
BACKGROUND: Porcine small intestinal submucosa (SIS) is an acellular, naturally derived extracellular matrix (ECM) that has been used for tissue remodeling and repair in numerous xenotransplantations. Although a vigorous immune response to xenogeneic extracellular matrix biomaterials is expected, to date there has been evidence for only normal tissue regeneration without any accompanying rejection. The purpose of this study was to determine the reason for a lack of rejection. METHODS: Mice were implanted s.c. with xenogeneic tissue, syngeneic tissue, or SIS, and the graft site analyzed histologically for rejection or acceptance. Additionally, graft site cytokine levels were determined by reverse transcriptase polymerase chain reaction and SIS-specific serum antibody isotype levels were determined by ELISA. RESULTS: Xenogeneically implanted mice showed an acute inflammatory response followed by chronic inflammation and ultimately graft necrosis, consistent with rejection. Syngeneically or SIS implanted mice, however, showed an acute inflammatory response that diminished such that the graft ultimately became indistinguishable from native tissue, observations that are consistent with graft acceptance. Graft site cytokine analysis showed an increase in interleukin-4 and an absence of interferon-gamma. In addition, mice implanted with SIS produced a SIS-specific antibody response that was restricted to the IgG1 isotype. Reimplantation of SIS into mice led to a secondary anti-SIS antibody response that was still restricted to IgG1. Similar results were observed with porcine submucosa derived from urinary bladder. To determine if the observed immune responses were T cell dependent, T cell KO mice were implanted with SIS. These mice expressed neither interleukin-4 at the implant site nor anti-SIS-specific serum antibodies but they did accept the SIS graft. CONCLUSIONS: Porcine extracellular matrix elicits an immune response that is predominately Th2-like, consistent with a remodeling reaction rather than rejection.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Evidence indicates that degradation products from ECM bioscaffolds condition antigen presentation and favor regulatory T lymphocyte induction and B lymphocyte tolerance, sustaining a pro-resolution set point that supports scaffold integration.
“Collectively, the evidence indicates that degradation products from ECMbioscaffolds condition antigen presentation and favor regulatory T lymphocyte induction and B lymphocyte tolerance, sustaining a pro-resolution set point that supports scaffold integration [2,26,34].”
From Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review (2025) · cites this paper as [34]
Xenogeneic ECM is commonly associated with a Th2-restricted humoral profile consistent with constructive outcome.
“Although B lymphocytes can generate antibodies to residual antigens-potentially accelerating scaffold degradation [27]-xenogeneic ECM is commonly associated with a Th2-restricted humoral profile consistent with constructive outcome [2,34].”
From Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review (2025) · cites this paper as [34]
The risk of immune responses from xenogeneic ECM can be greatly reduced by using proper preparation techniques.
“While xenogeneic ECM has the potential to cause immune responses, this risk can be greatly reduced by using proper preparation techniques64; similar ECM scaffolds derived from animals are FDA-approved for clinical applications such as heart valve replacement, facial reconstruction, and osteopathic implants62,65.”
From Towards organoid culture without Matrigel (2021) · cites this paper as [64]
Xenogeneic ECM has the potential to cause immune responses.
“While xenogeneic ECM has the potential to cause immune responses, this risk can be greatly reduced by using proper preparation techniques64; similar ECM scaffolds derived from animals are FDA-approved for clinical applications such as heart valve replacement, facial reconstruction, and osteopathic implants62,65.”
From Towards organoid culture without Matrigel (2021) · cites this paper as [64]
Cites
Functional diversity of helper T lymphocytes
Abbas, A. K., MURPHY, K. M. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,383 · see citing works
Good, A. H., Cooper, D. K. C., Malcolm, A. J., Ippolito, R. M., Koren, E., Neethling, F. A., YE, Y., Zuhdi, N., & Lamontagne, L. R. (1992) · PubMed · Cited by 639 · see citing works
Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR.
Overbergh, L., Valckx, D., Waer, M., & Mathieu, C. (1999) · Cytokine · doi:10.1006/cyto.1998.0426 · Cited by 623 · see citing works
TRANSPLANTED ACELLULAR ALLOGRAFT DERMAL MATRIX
Livesey, S. A., Herndon, D. N., Hollyoak, M. A., Atkinson, Y. H., & Nag, A. (1995) · Transplantation · doi:10.1097/00007890-199507150-00001 · Cited by 428 · see citing works
Bach, F. H., Ferran, C. J., Hechenleitner, P., Mark, W., Koyamada, N., Miyatake, T., Winkler, H. J. S., Badrichant, A., Candinas, D., & Ww, H. (1997) · Nature Medicine · doi:10.1038/nm0297-196 · Cited by 419 · see citing works
Bach, F. H., Winkler, H. J. S., Ferran, C. J., Hancock, W. W., & Robson, S. C. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10024-4 · Cited by 388 · see citing works
Auchincloss, H., & Sachs, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.433 · Cited by 372 · see citing works
Grünig, G., Corry, D. B., Leach, M. W., Seymour, B. W. P., Kurup, V. P., & Rennick, D. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1089 · Cited by 319 · see citing works
The Th1/Th2 paradigm and the allograft response
Strom, T. B. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80087-2 · Cited by 265 · see citing works
Intestine Submucosa and Polypropylene Mesh for Abdominal Wall Repair in Dogs
Clarke, K. M., Lantz, G. C., Salisbury, S. K., Badylak, S. F., Hiles, M. C., & Voytik, S. L. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0018 · Cited by 259 · see citing works
Self-citationBadylak, S. F., Kropp, B. P., McPherson, T. B., Liang, H.-L., & Snyder, P. W. (1998) · Tissue Engineering · doi:10.1089/ten.1998.4.379 · Cited by 205 · see citing works
Self-citationPiccotti, J. R., Chan, S. Y., VanBuskirk, A. M., EICHWALD, E. J., & Bishop, D. K. (1997) · Transplantation · doi:10.1097/00007890-199703150-00001 · Cited by 165 · see citing works
ENHANCED TYPE 2 AND DIMINISHED TYPE 1 CYTOKINES IN NEONATAL TOLERANCE
Chen, N., & Field, E. H. (1995) · Transplantation · doi:10.1097/00007890-199504150-00002 · Cited by 153 · see citing works
Gauthier, O., Bouler, J., Weiss, P., Bosco, J., Daculsi, G., & Aguado, E. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199910)47:1 · Cited by 148 · see citing works
Piccotti, J. R., Chan, S. Y., Goodman, R. E., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1951 · Cited by 131 · see citing works
Ghaffari‐Tabrizi‐Wizsy, N., Bauer, B., Villunger, A., Baier-Bitterlich, G., Altman, A., Utermann, G., Überall, F., & Baier, G. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01 · Cited by 108 · see citing works
PREVENTION OF TH1 RESPONSES IS CRITICAL FOR TOLERANCE1
Chen, N., Gao, Q., & Field, E. H. (1996) · Transplantation · doi:10.1097/00007890-199604150-00016 · Cited by 107 · see citing works
Vaughan, H. A., Loveland, B. E., & Sandrin, M. S. (1994) · Transplantation · doi:10.1097/00007890-199410270-00003 · Cited by 104 · see citing works
Th1 and Th2 Cytokines in Organ Transplantation: Paradigm Lost?
Busuttil, R. W., Zhai, Y., Ghobrial, F. M., & Kupiec‐Weglinski, J. W. (1999) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v19.i2.40 · Cited by 85 · see citing works
Shalhav, A. L., Elbahnasy, A. M., BERCOWSKY, E., KOVACS, G., BREWER, A. V., Maxwell, K. L., McDougall, E. M., & Clayman, R. V. (1999) · Journal of Endourology · doi:10.1089/end.1999.13.241 · Cited by 84 · see citing works
Soares, M. P., Lin, Y., Sato, K., Stuhlmeier, K. M., & Bach, F. H. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01530-3 · Cited by 81 · see citing works
Hodde, J. P., Badylak, S. F., & Shelbourne, K. D. (1997) · Tissue Engineering · doi:10.1089/ten.1997.3.27 · Cited by 78 · see citing works
Self-citationSmall Intestinal Submucosa as an Intra-Articular Ligamentous Graft Material: A Pilot Study in Dogs
Badylak, S. F., Toombs, J. P., Shelbourne, K. D., Hiles, M. C., Lantz, G. C., Sickle, D. V., & Aiken, S. W. (1994) · Veterinary and Comparative Orthopaedics and Traumatology · doi:10.1055/s-0038-1633133 · Cited by 75 · see citing works
Self-citationRecent advances in xenotransplantation
Sandrin, M. S., & McKenzie, I. F. C. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00011-4 · Cited by 55 · see citing works
Hancock, W. W. (1997) · World Journal of Surgery · doi:10.1007/s002689900327 · Cited by 51 · see citing works
INTERFERON-?? RECEPTOR SIGNALING IS NOT REQUIRED IN THE EFFECTOR PHASE OF THE ALLOIMMUNE RESPONSE1
Steiger, J. R., Nickerson, P. W., Hermle, M., et al. (1998) · Transplantation · doi:10.1097/00007890-199806270-00019 · Cited by 23 · see citing works
Intragraft cytokine gene expression in human liver allografts
Cosenza, C. A., Shirwan, H., Cramer, D. V., et al. (1995) · Liver Transplantation and Surgery · doi:10.1002/lt.500010105 · Cited by 23 · see citing works
Barriers to xenotransplantation
Bach, F. H., Soares, M. P., Lin, Y., & Ferran, C. J. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(99)00176-1 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Brown, B. N., Valentin, J. E., Stewart-Akers, A. M., McCabe, G. P., & Badylak, S. F. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.040 · Cited by 896 · see citing works
“An ECM scaffold consists primarily of the ECM constituent molecules, many of which are known to be highly conserved across species, thus mitigating many of the adverse components of the immune response [26,27].”
BackgroundSelf-citationExtracellular matrix-based materials for regenerative medicine
Hussey, G. S., Dziki, J. L., & Badylak, S. F. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0023-x · Cited by 844 · see citing works
Self-citationConsequences of ineffective decellularization of biologic scaffolds on the host response
Keane, T. J., Londono, R., Turner, N. J., & Badylak, S. F. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.054 · Cited by 613 · see citing works
Self-citationTowards organoid culture without Matrigel
Kozlowski, M. T., Crook, C. J., & Ku, H. T. (2021) · Communications Biology · doi:10.1038/s42003-021-02910-8 · Cited by 409 · see citing works
Progress towards biocompatible intracortical microelectrodes for neural interfacing applications
Jorfi, M., Skousen, J. L., Weder, C., & Capadona, J. R. (2015) · Journal of Neural Engineering · doi:10.1088/1741-2560/12/1/011001 · Cited by 384 · see citing works
Extracellular Matrix-Based Biomaterials and Their Influence Upon Cell Behavior
Cramer, M. C., & Badylak, S. F. (2020) · Annals of Biomedical Engineering · doi:10.1007/s10439-019-02408-9 · Cited by 196 · see citing works
Self-citationExtracellular Matrix Bioscaffolds as Immunomodulatory Biomaterials <sup/>
Dziki, J. L., Huleihel, L., Scarritt, M. E., & Badylak, S. F. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0538 · Cited by 141 · see citing works
Self-citationCosta, A., Naranjo, J. D., Londono, R., & Badylak, S. F. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025676 · Cited by 135 · see citing works
Self-citationRegulation of decellularized matrix mediated immune response
Chakraborty, J., Roy, S., & Ghosh, S. (2020) · Biomaterials Science · doi:10.1039/c9bm01780a · Cited by 130 · see citing works
Allman, A. J., McPherson, T. B., Merrill, L. C., Badylak, S. F., & Metzger, D. W. (2002) · Tissue Engineering · doi:10.1089/107632702753503054 · Cited by 119 · see citing works
Self-citationWang, Y., Bao, J., Wu, X., Wu, Q., Li, Y., Zhou, Y., Li, L., & Bu, H. (2016) · Scientific Reports · doi:10.1038/srep24779 · Cited by 101 · see citing works
Koch, H., Graneist, C., Emmrich, F., Till, H., Metzger, R., Aupperle, H., Schierle, K., Sack, U., & Boldt, A. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/948320 · Cited by 37 · see citing works
Vigneswaran, Y., Han, H., De Loera, R., Wen, Y., Zhang, X., Sun, T., Mora-Solano, C., & Collier, J. H. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35767 · Cited by 26 · see citing works
Extracellular Matrix for Myocardial Repair
Dziki, J. L., & Badylak, S. F. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-97421-7_8 · Cited by 25 · see citing works
Self-citationHost Response to Naturally Derived Biomaterials
Lopresti, S. T., & Brown, B. N. (2015) · Host Response to Biomaterials · doi:10.1016/b978-0-12-800196-7.00004-9 · Cited by 24 · see citing works
Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review
Romero, D. J., Hussey, G., & Capella-Monsonís, H. (2025) · Biologics · doi:10.3390/biologics5030028 · Cited by 7 · see citing works
“In multilayered tissues (e.g., urinary bladder, small intestine), mechanical delami-Biologics nation is often used to isolate specific ECM-rich layers [34,100–102].”
InfluentialMatrix-Bound Nanovesicles Promote Prohealing Immunomodulation Without Immunosuppression
Capella-Monsonís, H., Crum, R. J., D’Angelo, W., Hussey, G. S., & Badylak, S. F. (2025) · Tissue Engineering Part A · doi:10.1089/ten.tea.2024.0238 · Cited by 5 · see citing works
Self-citation
- Authors
- Allman, A. J., McPherson, T. B., Badylak, S. F., Merrill, L. C., Kallakury, B., Sheehan, C., Raeder, R. H., & Metzger, D. W.
- Affiliations
- Albany Medical College (US)
- University of Health Sciences and Pharmacy (US)
- Purdue University West Lafayette (US)
- Corresponding author
- Metzger, Dennis W.
- Venue
- Transplantation
- Published
- 2001-06
- Volume
- 71
- Issue
- 11
- Pages
- 1631-1640
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1963940108
- Cited by
- 388
- References
- 28
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 11 · 2023: 10 · 2022: 14 · 2021: 21 · 2020: 18 · 2019: 16 · 2018: 11 · 2017: 18 · 2016: 16 · 2015: 19 · 2014: 27 · 2013: 31 · 2012: 15
- FWCI
- 13.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl060359-04)
- National Heart, Lung, and Blood Institute (HL60359)
- Topics
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- porcine small intestinal submucosa, xenotransplantation, graft rejection, Th2 immune response, IL-4, interferon-gamma, IgG1 antibody response, T cell-dependent immunity, tissue remodeling, graft necrosis, chronic inflammation
- MeSH terms
- Animals, Antibody Formation, Urinary Bladder, Extracellular Matrix, Intestinal Mucosa, Intestine, Small, Mice, Inbred BALB C, Mice, Inbred C57BL, Mucous Membrane, RNA, Messenger, Swine, T-Lymphocytes, Transplantation, Heterologous, Transplantation, Isogeneic, Cytokines, Mice, Knockout, Th2 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review